Skip to main content

Animations

The Parkinson's Precision Medicine Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.


  • Parkinson's Biomarkers Study Participants Share Their Experience

    Parkinson's Biomarkers Study Participants Share Their Experience

    Sunday Night Australia taped exclusive interviews with friends of the Foundation last month, including PPMI control participant Marc Jaffe, his wife Karen and Dr. Ken Marek.
    Learn more Save for later

  • Jon Surine: 'I Don't Want to Be Defined by Parkinson's, I Want to Help Define It'

    Jon Surine: 'I Don't Want to Be Defined by Parkinson's, I Want to Help Define It'

    In the Spring 2012 issue of 'Accelerating the Cure,' we hear directly from PPMI participant Jon Surine.
    Learn more Save for later

  • Default content image

    Partner Scientist Runs Marathon for Parkinson's

    Chris Coffey, PhD, director of the Clinical Trials Statistical and Data Management Center at the University of Iowa ran the 2011 Bank of America Chicago Marathon.
    Learn more Save for later

  • Bob Harmon and Family: Turning a Parkinson's Diagnosis into Action

    Bob Harmon and Family: Turning a Parkinson's Diagnosis into Action

    The news of a Parkinson’s diagnosis can be very alarming. Team Fox member and mentor Bob Harmon recalls March 3, 2006 as the “day the earth stood still.”
    Learn more Save for later

  • Default content image

    New Blood Test That Could Diagnose Parkinson's Is Being Studied

    WebMD is reporting on a potential blood test (a.k.a. biomarker) for Parkinson's disease that's resulted from a project funded by The Michael J. Fox Foundation.
    Learn more Save for later

  • Cleveland Clinic Joins 23andMe, Michael J. Fox Foundation in Search for Genetic Clues to PD

    Cleveland Clinic Joins 23andMe, Michael J. Fox Foundation in Search for Genetic Clues to PD

    The Cleveland Clinic today announced that it is joining an ongoing effort from personal genetics company 23andMe to recruit 10,000 Parkinson’s disease (PD) patients to contribute their DNA
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.